Bevacizumab/Carboplatin/Paclitaxel/Pembrolizumab Regimen

Preferred Label : Bevacizumab/Carboplatin/Paclitaxel/Pembrolizumab Regimen;

NCIt synonyms : Bevacizumab/Carboplatin/Paclitaxel/Pembrolizumab; Paclitaxel/Carboplatin Plus Pembrolizumab/Bevacizumab; Avastin/Carboplatin/Taxol/Keytruda; Bevacizumab-Carboplatin-Paclitaxel-Pembrolizumab;

NCIt related terms : Carboplatin and Paclitaxel (CP), Bevacizumab-maly, Pembrolizumab; Carboplatin and Paclitaxel (CP), Bevacizumab-awwb, Pembrolizumab; Carboplatin and Paclitaxel (CP), Bevacizumab, Pembrolizumab; Carboplatin and Paclitaxel (CP), Bevacizumab-onbe, Pembrolizumab; Carboplatin and Paclitaxel (CP), Bevacizumab-aybi, Pembrolizumab; Carboplatin and Paclitaxel (CP), Bevacizumab-adcd, Pembrolizumab; Carboplatin and Paclitaxel (CP), Bevacizumab-equi, Pembrolizumab; Carboplatin and Paclitaxel (CP), Bevacizumab-bvzr, Pembrolizumab;

NCIt definition : A regimen consisting of bevacizumab, carboplatin, paclitaxel and pembrolizumab that may be used in the treatment of cervical and vaginal cancer.;

NCI Metathesaurus CUI : CL1927613;

Codes from synonyms : 127610; 127240; 60810; 127166; 127314; 127388; 127536; 127462;

Details

Origin ID

C205354;

chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Carboplatin [NCIt concept]
- Paclitaxel [NCIt concept]
- Pembrolizumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Cervical Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients